Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
4.270
-0.230 (-5.11%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lyra Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 22.06 | 40.58 | 22.35 | 32.55 | 45.75 | 74.59 | Upgrade
|
| Short-Term Investments | - | - | 80.4 | 65.34 | - | - | Upgrade
|
| Cash & Short-Term Investments | 22.06 | 40.58 | 102.75 | 97.89 | 45.75 | 74.59 | Upgrade
|
| Cash Growth | -57.28% | -60.51% | 4.96% | 113.99% | -38.67% | 660.53% | Upgrade
|
| Prepaid Expenses | 0.96 | 2.45 | 2.07 | 2.94 | 2.17 | 1.32 | Upgrade
|
| Total Current Assets | 23.02 | 43.03 | 104.82 | 100.83 | 47.92 | 75.92 | Upgrade
|
| Property, Plant & Equipment | 18.7 | 21.33 | 35.28 | 4.47 | 5.86 | 4.47 | Upgrade
|
| Other Long-Term Assets | 1.99 | 1.99 | 2.5 | 4.67 | 1.09 | 0.45 | Upgrade
|
| Total Assets | 43.71 | 66.35 | 142.6 | 109.97 | 54.87 | 80.83 | Upgrade
|
| Accounts Payable | 0.63 | 1.18 | 3.13 | 2.62 | 3.13 | 0.92 | Upgrade
|
| Accrued Expenses | 1.1 | 2.11 | 8.14 | 8.37 | 3.63 | 2.83 | Upgrade
|
| Current Portion of Leases | 4.68 | 4.12 | 5.43 | 1.55 | 1.07 | 0.99 | Upgrade
|
| Current Unearned Revenue | 0.01 | 0.4 | 1.66 | 1.28 | 9.79 | - | Upgrade
|
| Other Current Liabilities | 3.06 | 4.82 | 1.23 | 0.66 | 0.63 | 0.15 | Upgrade
|
| Total Current Liabilities | 9.48 | 12.63 | 19.6 | 14.47 | 18.25 | 4.88 | Upgrade
|
| Long-Term Leases | 26.7 | 30.26 | 21.45 | 0.67 | 0.38 | 1.45 | Upgrade
|
| Long-Term Unearned Revenue | 11.86 | 11.86 | 12.14 | 14.08 | 1.93 | - | Upgrade
|
| Total Liabilities | 48.04 | 54.75 | 53.18 | 29.21 | 20.55 | 6.34 | Upgrade
|
| Common Stock | 0 | 0.07 | 0.06 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 422.43 | 416.32 | 400.69 | 329.39 | 227.7 | 224.36 | Upgrade
|
| Retained Earnings | -426.76 | -404.79 | -311.36 | -248.68 | -193.4 | -149.88 | Upgrade
|
| Comprehensive Income & Other | - | - | 0.03 | 0.01 | - | - | Upgrade
|
| Total Common Equity | -4.33 | 11.59 | 89.42 | 80.75 | 34.32 | 74.49 | Upgrade
|
| Shareholders' Equity | -4.33 | 11.59 | 89.42 | 80.75 | 34.32 | 74.49 | Upgrade
|
| Total Liabilities & Equity | 43.71 | 66.35 | 142.6 | 109.97 | 54.87 | 80.83 | Upgrade
|
| Total Debt | 31.38 | 34.38 | 26.88 | 2.22 | 1.45 | 2.44 | Upgrade
|
| Net Cash (Debt) | -9.32 | 6.2 | 75.87 | 95.68 | 44.29 | 72.15 | Upgrade
|
| Net Cash Growth | - | -91.83% | -20.70% | 116.01% | -38.61% | 1013.14% | Upgrade
|
| Net Cash Per Share | -6.49 | 4.76 | 76.17 | 158.22 | 170.54 | 419.98 | Upgrade
|
| Filing Date Shares Outstanding | 1.77 | 1.32 | 1.19 | 0.64 | 0.26 | 0.26 | Upgrade
|
| Total Common Shares Outstanding | 1.64 | 1.31 | 1.14 | 0.64 | 0.26 | 0.26 | Upgrade
|
| Working Capital | 13.54 | 30.39 | 85.22 | 86.36 | 29.67 | 71.03 | Upgrade
|
| Book Value Per Share | -2.63 | 8.85 | 78.14 | 126.86 | 131.91 | 288.01 | Upgrade
|
| Tangible Book Value | -4.33 | 11.59 | 89.42 | 80.75 | 34.32 | 74.49 | Upgrade
|
| Tangible Book Value Per Share | -2.63 | 8.85 | 78.14 | 126.86 | 131.91 | 288.01 | Upgrade
|
| Machinery | 4.86 | 4.89 | 3.4 | 5.35 | 5.59 | 3.58 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 0.5 | Upgrade
|
| Leasehold Improvements | 0.55 | 0.49 | 0.46 | 0.4 | 2.11 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.